The updated version of the Union's Clinical Practice Rules is in line with the Rules of Good Clinical Practice of the International Council for Harmonization of Technical Requirements for Pharmaceuticals for Human Use (ICH). This will allow for recognizing the results of trials conducted within and outside the EAEU.
Primarily, it will support market participants (clinical centers) of the EAEU countries that conduct international multicenter trials. Manufacturers will be able to present the results of clinical trials when registering medicines abroad without repeating trials, which will contribute to the export attractiveness of the EAEU pharmaceutical products and decrease the burden on business due to the exclusion of repeating trials for foreign registration of medicinal products.